drugset / Trial / NCT00928447
Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the effect and safety of rHuPH20 or placebo for the prevention and treatment of skin allergic reaction to nickel. The study drug and placebo will be administered by intradermal injection.
Timeline
- Start
- 2009-06-23
- Primary completion
- 2009-09-13
- Completion
- 2009-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rHuPH20 | Protein / enzyme biologic | 3000 iu | Other |